Miller Symposium Schedule

Opening Remarks 

Shota Atsumi, Chair, Miller Committee

Estella Atekwana, Dean, College of Letters and Science

Opening Plenary

Michael Jung, UC Los Angeles

"Drug Discovery in Academia: a Progress Report"

Paul Wender, Stanford University

"Translational Science: The Chemistry-Biology-Medicine Continuum"

Break

Najafi Award Presentation

Annaliese Franz, UC Davis

Alumni Speaker

Mike Di Maso, Merck

"Using Flow Chemistry to Design Green and Sustainable Processes at Merck"

Break

Opening Remarks 

Dave Goodin, Chair, Department of Chemistry

Dylan Murray, UC Davis

"Low Complexity Protein Assembly Mechanisms in Neurodegenerative Disease"

Lindsey Ingerman James, University of North Carolina

"Altering the H3 Methylation Landscape through Degradation of Methyl-Lysine Reader Proteins"

Nicholas Meanwell, formerly of Bristol Myers Squibb

"Inhibitors of HIV-1 Maturation”

Special Address

Arthur Wellman, Jr., Pranger Law PC

Rachel Haurwitz, Caribou Biosciences

"Advancing the clinical development of a CRISPR genome-edited allogeneic CAR-T cell therapy"

Daniel Starczynowski, Cincinnati Children's Hospital Medical Center 

"Inflammation as a driver and therapeutic target in leukemia"

Break

PLENARY SPEAKER

Dame Margaret Brimble, University of Auckland

"Natural Product Synthesis: A Crucible for New Method Development and Drug Discovery."